Trial Profile
Exercise and Pharmacotherapy for Anxiety in Cardiac Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 May 2022
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Anxiety
- Focus Therapeutic Use
- Acronyms UNWIND
- 12 May 2022 Results from Six Month Follow-up of this trial published in the American Heart Journal
- 18 Aug 2021 Primary endpoint has been met. (Change in Hospital Anxiety and Depression Scale (HADS), Anxiety), as per Results published in the JAMA Psychiatry
- 18 Aug 2021 Results published in the JAMA Psychiatry